Here, we aimed to develop the PA63 transporter for delivery of recombinant human His6-NDPK-A into the cytosol of human breast cancer cells in order to increase the cytosolic levels of NDPK-A in such cancer cells and reduce their motility. Here, NME1 is linked to breast cancer.